Alzheimer disease (AD) and related disorders are the sixth leading cause of death in the United States (8) and the fifth leading cause for people age 65 and older (1). Whereas mortality attributed to several major causes of death including heart disease, breast cancer, and stroke is decreasing, mortality attributed to AD has increased dramatically during the last 15 yr (1). Between 2002 and 2006, the total number of deaths attributed to AD increased by nearly 46.1% (1), making AD a major public health concern.
Increasing evidence from observational epidemiologic studies suggests that physical activity may reduce the risk of developing AD and related disorders (18,28,30). In a meta-analysis of 16 prospective epidemiologic studies on the effect of physical activity and risk of neurodegenerative disease, physical activity was found to be associated with a reduced risk of both dementia and AD by 28% and 45%, respectively (18). The effects of increased physical activity and cardiorespiratory fitness (CRF) on cognitive function in healthy adults have also been examined in randomized controlled trials (RCTs). However, results were mixed. Although some RCTs reported that exercise programs maintained or improved cognitive function compared with controls, others found no benefit of exercise for cognitive function (28). A Cochrane review (3) evaluated 11 RCTs examining the effectiveness of aerobic exercise interventions aimed at improving CRF for healthy older adults, specifically to enhance cognitive function. The review found suggestive evidence of potential improvements in cognitive capacity in eight of these studies, with the most promising results for cognitive speed, motor function, and auditory and visual attention; however, the majority of comparisons were not statistically significant. Another recent review of RCTs in this area found little evidence of an association between activity and cognitive outcomes but noted that almost all studies in this area have serious methodological limitations (30). Nonetheless, given the strength of the evidence from observational studies and animal models, the Physical Activity Guidelines Advisory Committee and the American College of Sports Medicine recently concluded that cardiovascular fitness and higher levels of physical activity reduce the risk of cognitive decline and dementia and that physical activity in previously sedentary older adults can improve cognitive performance, particularly for complex tasks requiring executive control (9,25).
Despite similar beneficial outcomes reported across prospective epidemiologic studies, study designs and findings vary greatly (18). A major source of variation involves assessment of physical activity. A substantial proportion of previous epidemiologic studies might not have accurately quantified physical activity levels (18,28). Physical activity has most often been self-reported and therefore subjected to reporting bias (12,28). CRF is an objective reproducible measure that correlates strongly with habitual physical activity and is more highly correlated with many health outcomes than self-reported physical activity (7). Consistent evidence has suggested an inverse relationship between CRF and both cardiovascular disease and all-cause mortality (7,16,31). This evidence suggests that CRF may also be associated with lower dementia risk because vascular damage is a notable risk factor for developing AD and vascular dementia (VaD) (19). One way to examine this possible relationship is to study deaths for which dementia has been assigned as a contributory cause (hereafter called “dementia mortality”). Only one prospective study, by Middleton et al. (24), has suggested potential benefits of self-reported physical activity for reducing dementia mortality. The goal of the present study was to investigate the association between CRF and dementia mortality in a large prospective cohort of adults, thus improving previous research by using an objective measure of individuals’ physical activity habits.
Participants were 14,811 women and 45,078 men, age 20–88 yr, who had a baseline physician examination and clinical assessment at the Cooper Clinic in Dallas, TX, during 1970–2001. Individuals were included in the study if they met the following criteria: 1) enrollment in the Aerobics Center Longitudinal Study; 2) completion of a maximal treadmill exercise test, achieving at least 85% of their age-predicted maximal heart rate (220 − age (yr)); and 3) completion of at least 1 yr of follow-up. The majority of participants were white, well-educated, and typically employed or formerly employed in professional positions. Participants completed a written informed consent, indicating that they agreed to participate in the clinical examination and the follow-up study. The Cooper Institute Institutional Review Board annually reviewed and approved the study protocol.
The baseline examination was conducted after an overnight fast. Published reports have described the examination in detail (7,16). In brief, the examination consisted of an extensive self-reported personal and family medical history, a questionnaire on demographic information and health habits, blood chemistry tests, and other clinical measurements. Body mass index (BMI) (kg·m−2) was computed from measured height and weight on a standard physician’s balance beam scale and stadiometer. Resting blood pressures were recorded as the first and fifth Korotkoff sounds, using standard auscultation methods. Hypertension was defined by measured resting systolic (≥140 mm Hg) or diastolic (≥90 mm Hg) blood pressure or a history of physician diagnosis. Serum samples were analyzed for lipids and glucose using standardized automated bioassays. Diabetes was defined as fasting plasma glucose concentration of ≥7.0 mmol·L−1 (126 mg·dL−1), a history of physician diagnosis, or insulin use. Health status was based on the presence of physician-diagnosed conditions (myocardial infarction, stroke, or cancer). Smoking habits and alcohol intake were obtained from a standardized questionnaire.
CRF was assessed by a maximal symptom-limited treadmill exercise test following a modified Balke protocol (5). Patients began walking at 88 m·min−1 without elevation. After the first minute, elevation was increased to 2% and thereafter increased 1% per minute until the 25th minute. After 25 min, elevation did not change, whereas speed was increased by 5.4 m·min−1 for each minute increment until test termination. Patients were encouraged to give maximal effort. The test end point was volitional exhaustion or termination by the physician for medical reasons. Exercise duration in this protocol is highly correlated with measured maximal oxygen uptake in men (26) (r = 0.92) and women (27) (r = 0.94). Thus, CRF in this study is equivalent to maximal aerobic power. We estimated maximal METs (1 MET = 3.5 mL O2 uptake·kg−1·min−1) from the final treadmill speed and grade (2). Patients were grouped into tertiles on the basis of their MET values. We classified the least fit tertile as low fit, the next third as middle fit, and the upper tertile as high fit. Maximal MET values for the three fitness categories were low, <9.9; middle, 9.9 to 12.2; and high, ≥12.2. Abnormal exercise ECG responses included rhythm and conduction disturbances and ischemic ST–T wave abnormalities (16). In a previous study, three physicians who read a random sample of 357 patient records agreed with 90% of the ECG interpretations (16).
All participants were followed for mortality from their baseline visit through December 31, 2003. The National Death Index was the primary data source for mortality surveillance. The underlying cause of death was determined from the National Death Index report or by a nosologist’s review of official death certificates obtained from the department of vital records in the decedent’s state of residence. VaD mortality was defined by International Classification of Diseases, Ninth Revision code 290 before 1999 and Tenth Revision codes F01 and F03 during 1999–2003. AD mortality was defined by International Classification of Diseases, Ninth Revision code 331.0 before 1999 and Tenth Revision code G30 during 1999–2003. Total dementia included VaD and AD. We computed person-years of exposure as the sum of follow-up time among decedents and survivors. During a mean 17 yr of follow-up, 4047 deaths were identified, 164 of which were dementia mortality (72 vascular dementia and 92 AD).
Baseline characteristics of the population were estimated separately for survivors and decedents and also specifically for dementia decedents. Differences in covariates between survivors and decedents were tested using Student’s t-tests for continuous variables and chi-square tests for categorical variables. Cox proportional hazards models were used to estimate adjusted hazard ratios (HRs), 95% confidence intervals (CIs), mortality rates (deaths per 10,000 person-years of follow-up), and linear trends for VaD, AD, and total dementia mortality for each fitness category. When calculating HRs, the low-fitness group was used as the reference category. METs were also entered into the model as a continuous variable.
Cumulative hazard plots grouped by exposure suggested no appreciable violations of the proportional hazards assumption. We excluded events that occurred during the first year of follow-up to reduce potential confounding caused by procedure-related deaths and the influence of undetected subclinical disease at baseline. To examine potential modifying effects of selected variables on the fitness–dementia association, we conducted Cox regression analyses according to strata of age (<55 vs ≥55 yr), sex (female vs male), BMI (<25 vs ≥25 kg·m−2), and chronic medical conditions (presence/absence). Tests for multiplicative interaction between a variable representing METs in 1-MET increments and other risk factors in relation to total dementia risk were performed by likelihood ratio tests, which compared the models with and without interaction terms. All P values are based on two-sided tests, with an α level of 0.05. All statistical analyses were performed using SAS statistical software, version 9.1 (SAS, Inc., Cary, NC).
Table 1 presents participants’ selected baseline demographic, clinical, and health habit characteristics by vital status. The mean ± SD age of the cohort (n = 59,889) was 43.5 ± 10.0 yr. Approximately 25% of participants were women. Compared with survivors, participants who died were older, had lower CRF, and had less favorable risk factor profiles for cardiovascular diseases. There were 164 dementia deaths (72 VaD, 92 AD) during 1,012,125 person-years of exposure.
Table 2 shows the relationship between CRF levels and the risk of VaD, AD, and total dementia mortality. After adjusting for age and sex and compared with those in the low-fitness category, participants in the middle- and high-fitness categories had significantly lower HRs for VaD mortality (HR = 0.27, CI = 0.12–0.60 and HR = 0.46, CI = 0.21–0.99, respectively) and total dementia mortality (HR = 0.49, CI = 0.31–0.78 and HR = 0.59, CI = 0.35–0.99, respectively), P trend < 0.01 for each. The lower risks of dementia mortality for those with higher CRF levels remained significant after additional adjustment for BMI, current smoking, alcohol intake, abnormal exercise ECG responses, and other medical conditions. The results for AD mortality were not statistically significant. Adjusting for blood pressure, lipids, and glucose as continuous scores did not materially change the results (data not shown).
We next examined the relationship between CRF and each of the three mortality outcomes representing maximal METs as a continuous variable (Table 3). Adjusted for age, sex, and examination year, the HR for VaD mortality associated with each 1-unit increment in maximal METs was 0.84 (95% CI = 0.75–0.95). CRF remained inversely associated with VaD death risk after additional adjustment for other risk factors (P = 0.01). The magnitudes of the inverse associations were similar between CRF and the risk of AD and total dementia mortality (model 2; HR = 0.87, CI = 0.76–0.99 and HR = 0.86, CI = 0.78–0.94, respectively). Similar results were obtained when blood pressure, lipids, and glucose were adjusted for as continuous scores (data not shown).
Finally, we examined whether other risk predictors modified the association between CRF and total dementia mortality (Table 4). Multivariable analyses showed that each 1-MET increment of maximal exercise was associated with a 9% to 34% lower dementia mortality risk in these groups, with the greatest benefit of higher CRF in those having chronic medical conditions (P < 0.05 for most strata). The consistency in the direction and magnitude of association between CRF and dementia mortality suggested that there was little effect modification across risk factor categories. A possible exception to this generalization may be a greater effect of CRF for those age <55 yr at baseline, compared with their older counterparts. The test for interaction between age and fitness was significant (P for interaction = 0.02, not shown in the table).
Figure 1 depicts the modifying effect of baseline age on the association between CRF and dementia mortality. As in Table 4, age was grouped into two categories (<55 and ≥55 yr). After adjusting for all the covariates, there was a significant reduction in risk of total dementia death in the top two tertiles of CRF for those age <55 yr, compared with the lowest CRF category (P trend = 0.0001). Although there was no suggestion of a gradient of declining risk for those age ≥55 yr, those in the two higher CRF groups had lower risk of dementia mortality than those in the low-fitness group. The figure suggests that the greatest reduction in dementia mortality may have occurred between the low and middle tertiles of CRF, where the HR dropped by two-thirds.
In this large prospective study of men and women followed for an average of 17 yr, individuals with higher levels of CRF had significantly lower mortality for both VaD and total dementia. The association remained after adjustments for potential confounding variables including age, sex, examination year, BMI, smoking status, alcohol intake, abnormal ECG responses, and baseline medical conditions. The association was particularly strong for VaD mortality; persons in the middle- and high-fitness categories had a 73% and 69% lower mortality risk for vascular dementia, respectively, compared with those in the low-CRF category. No beneficial effect of CRF on AD mortality risk was detected in the analysis of CRF tertiles.
When CRF was evaluated using continuous variables, an approach with greater statistical power than the tertile analysis, each 1-unit increase in maximal MET expenditure was associated with reductions in VaD, AD, and total dementia mortality of 18%, 13%, and 14%, respectively, after accounting for potential risk factors. Our findings are consistent with those reported by Barnes et al. (6). In their longitudinal study of healthy older adults, higher baseline fitness was positively associated with preservation and enhancement of cognitive function during a 6-yr follow-up period.
A strong inverse trend in the adjusted risk of dementia mortality was observed across the three CRF categories in the younger group (<55 yr). The adjusted risk of dementia mortality was the lowest in the high-CRF group and the highest in the low-CRF group. The beneficial effect of greater CRF was approximately equal when comparing younger and older individuals in the middle-fitness category to those in the low-fitness category. For both age groups, the risk for those in the middle-fitness category was more than 60% lower than the corresponding risk for those in the lowest fitness category. Younger individuals seemed to receive more protective benefits from being in the high-fitness category than did older individuals. It is possible that the latter finding results from physical activity over more years of follow-up for participants who were younger at baseline or more intense, frequent, or lengthy periods of activity during follow-up; we do not have CRF measures for participants during the follow-up period. This result may also be an artifact of the relatively small number of individuals age 55 or older in the high-fitness category at baseline (n = 1144). Additional research in this area is warranted.
CRF may preserve cognitive function through a variety of plausible cellular and molecular mechanisms, including increasing cerebral blood flow and oxygen delivery (10), enhancing neuronal plasticity (13), inducing fibroblast growth factors in the hippocampus and cerebellum (17), reducing oxidative stress and inflammation (20), increasing brain volume (11), and stimulating neuronal creation and survival (13). Fitness may also lower the risk of several medical conditions, such as cardiovascular disease, cerebrovascular disease, hypertension, and diabetes, all of which are important risk factors linked to cognitive decline (4,21). In addition, results from randomized trials suggest that increasing the level of physical activity may enhance cognition in older adults at risk for AD (22). Participating in physical activity may also provide an enriched social environment. Individuals may benefit from both the activity itself and the social interaction. Animal studies have shown that mice exposed to an “enriched environment” have significantly lower levels of amyloid deposits, which are associated with AD, compared with animals raised under normal conditions (23). Results from longitudinal studies also suggest that socially isolated older adults are at a higher risk of all-cause mortality (29) and dementia (14), compared with those with close social ties or better social support.
The current study has several strengths. First, the use of standardized and objective measurements of fitness reduced the likelihood of exposure misclassification, compared with self-reported measures of physical activity. No previous studies have examined the association between physical activity and dementia mortality using CRF as their fitness measurement. Second, the extensive and standardized baseline covariate measurement minimized potential confounding due to undetected subclinical diseases at baseline. Lastly, the prospective study design, with a mean follow-up of 17 yr, provided a sufficiently large number of dementia mortality cases to enable us to examine the association between CRF and both AD and VaD.
Several limitations of this study should be considered. First, the generalizability of our findings may be limited because of the homogeneity of our study population. Participants were predominately white and well educated, had middle to upper socioeconomic status (SES), and were physically able to complete a fitness test. Whether similar findings would be obtained in adults from different ethnic or SES backgrounds or with functional limitations is not clear. On the other hand, the homogeneity of participants strengthens the study’s internal validity by minimizing potential confounding attributable to income, education, or SES differences. Second, there were no baseline or longitudinal data on cognitive performance. It is possible that some individuals in the study had preclinical or early-stage disease at baseline, although the average 17 yr of follow-up limits that possibility. Third, there was insufficient information on medication use, menopausal status, family history of dementia, or dietary habits to control for these factors. These unmeasured factors may have introduced residual confounding. However, it seems unlikely that these factors would explain all of the observed association between CRF and dementia mortality. It should also be noted that the analysis of dementia mortality may be affected by the fact that we studied an incomplete cohort, one in which the majority of participants remained alive. Because the dynamics of dementia mortality could differ at older ages, estimates of dementia mortality will remain uncertain until most or all of the cohort has died. The relatively small number of participants and dementia deaths in the middle- and high-fitness groups for ages 55 and older may have affected the results. Thus, it will be useful to continue to follow this cohort to completion. In terms of exposure assessment, CRF was assessed only at baseline. We were unable to explore changes in fitness that may have occurred during follow-up. It is possible that low-fit individuals increased their fitness levels at some point during the follow-up or that high-fit individuals decreased their fitness levels. Misclassification associated with changing levels of physical activity would likely underestimate the magnitude of the association observed in the present study. In addition, other relevant health behaviors and other time-varying covariates were not measured during the years of follow-up. It is possible that these factors changed over time. Such changes may introduce residual confounding. Finally, the ascertainment of dementia mortality may be limited by variation in diagnosis or inconsistent reporting of dementia as the underlying or contributory cause of death on death certificates (15). Again, the high SES and homogeneity of our sample may help to ameliorate this concern. Given their high SES, study participants were likely to have had accessible health care of relatively high quality, which may contribute to more reliable diagnoses. Participants’ homogeneity similarly may have been associated with relatively nondifferential reporting of dementia diagnoses on death certificates.
This study found that higher levels of CRF were associated with lower risk of AD mortality, VaD mortality, and total dementia mortality in a large cohort of women and men. CRF is an objective measure of physical activity habits. The results persisted after adjustment for clinical variables. Clinicians should encourage patients to maintain an active lifestyle. These findings support physical activity promotion campaigns by public health organizations and nonprofit organizations such as the Alzheimer’s Association and should encourage individuals to be physically active. Following current physical activity recommendations (32) will keep most individuals out of the low-fitness category and may therefore reduce dementia mortality. Consistent with current physical activity recommendations, results also suggest that having even more activity than the recommended level may bring added benefits.
The study was supported by National Institutes of Health grants AG06945, HL62508, and R21DK088195.
The authors thank the Cooper Clinic physicians and technicians for collecting the baseline data and staff at the Cooper Institute for data entry and data management.
The authors declare no conflicts of interest.
The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health or constitute endorsement by the American College of Sports Medicine.
1. Alzheimer’s Association. 2010 Alzheimer’s disease facts and figures. Alzheimers Dement. 2010; 6 (2): 158–94.
2. American College of Sports Medicine. ACSM’s Guidelines for Exercise Testing and Prescription. 7th ed. Philadelphia (PA): Lippincott Williams & Wilkins; 2000. p. 219–24.
3. Angevaren M, Aufdemkampe G, Verhaar HJ, Aleman A, Vanhees L. Physical activity and enhanced fitness to improve cognitive function
in older people without known cognitive impairment. Cochrane Database Syst Rev. 2008; CD005381: 1–71.
4. Anstey K, Christensen H. Education, activity, health, blood pressure and apolipoprotein E as predictors of cognitive change in old age: a review. Gerontology. 2000; 46 (3): 163–77.
5. Balke B, Ware RW. An experimental study of physical fitness
of Air Force personnel. U S Armed Forces Med J. 1959; 10 (6): 675–88.
6. Barnes DE, Yaffe K, Satariano WA, Tager IB. A longitudinal study of cardiorespiratory fitness and cognitive function
in healthy older adults. J Am Geriatr Soc. 2003; 51 (4): 459–65.
7. Blair SN, Kampert JB, Kohl HW 3rd, et al.. Influences of cardiorespiratory fitness and other precursors on cardiovascular disease and all-cause mortality in men and women. JAMA. 1996; 276 (3): 205–10.
8. Centers for Disease Control and Prevention [Internet]. Atlanta (GA): Centers for Disease Control. FastStats: Deaths and Mortality. [cited 2010 Jul 31]. Available from: http://www.cdc.gov/nchs/fastats/deaths.htm
9. Chodzko-Zajko WJ, Proctor DN, Fiatarone Singh MA, et al.. American College of Sports Medicine Position Stand: exercise and physical activity for older adults. Med Sci Sports Exerc. 2009; 41 (7): 1510–30.
10. Churchill JD, Galvez R, Colcombe S, Swain RA, Kramer AF, Greenough WT. Exercise, experience and the aging brain. Neurobiol Aging. 2002; 23 (5): 941–55.
11. Colcombe SJ, Erickson KI, Scalf PE, et al.. Aerobic exercise training increases brain volume in aging humans. J Gerontol A Biol Sci Med Sci. 2006; 61 (2): 1166–70.
12. Coley N, Andrieu S, Gardette V, et al.. Dementia prevention: methodological explanations for inconsistent results. Epidemiol Rev. 2008; 30: 35–66.
13. Cotman CW, Engesser-Cesar C. Exercise enhances and protects brain function. Exerc Sport Sci Rev. 2002; 30 (2): 75–9.
14. Fratiglioni L, Paillard-Borg S, Winblad B. An active and socially integrated lifestyle in late life might protect against dementia. Lancet Neurol. 2004; 3 (6): 343–53.
15. Ganguli M, Rodriguez EG. Reporting of dementia on death certificates: a community study. J Am Geriatr Soc. 1999; 47 (7): 842–9.
16. Gibbons LW, Mitchell TL, Wei M, Blair SN, Cooper KH. Maximal exercise test as a predictor of risk for mortality from coronary heart disease in asymptomatic men. Am J Cardiol. 2000; 86 (1): 53–8.
17. Gómez-Pinilla F, So V, Kesslak JP. Spatial learning and physical activity contribute to the induction of fibroblast growth factor: neural substrates for increased cognition associated with exercise. Neuroscience. 1998; 85 (1): 53–61.
18. Hamer M, Chida Y. Physical activity and risk of neurodegenerative disease: a systematic review of prospective evidence. Psychol Med. 2009; 39 (1): 3–11.
19. Hendrie HC, Albert MS, Butters MA, et al.. The NIH Cognitive and Emotional Health Project. Report of the Critical Evaluation Study Committee. Alzheimers Dement. 2006; 2 (1): 12–32.
20. Kiraly MA, Kiraly SJ. The effect of exercise on hippocampal integrity: review of recent research. Int J Psychiatry Med. 2005; 35 (1): 75–89.
21. Kivipelto M, Helkala EL, Laakso MP, et al.. Apolipoprotein E epsilon4 allele, elevated midlife total cholesterol level, and high midlife systolic blood pressure are independent risk factors for late-life Alzheimer disease
. Ann Intern Med. 2002; 137 (3): 149–55.
22. Lautenschlager NT, Cox KL, Flicker L, et al.. Effect of physical activity on cognitive function
in older adults at risk for Alzheimer disease
: a randomized trial. JAMA. 2008; 300 (9): 1027–37.
23. Lazarov O, Robinson J, Tang YP, et al.. Environmental enrichment reduces Abeta levels and amyloid deposition in transgenic mice. Cell. 2005; 120 (5): 701–13.
24. Middleton LE, Mitnitski A, Fallah N, Kirkland SA, Rockwood K. Changes in cognition and mortality in relation to exercise in late life: a population based study. PLoS One. 2008; 3 (9): e3124.
25. Physical Activity Guidelines Advisory Committee. Physical Activity Guidelines Advisory Committee Report, 2008. Washington (DC): Department of Health and Human Services; 2008. p. G8-27–32.
26. Pollock ML, Bohannon RL, Cooper KH, et al.. A comparative analysis of four protocols for maximal treadmill stress testing. Am Heart J. 1976; 92 (1): 39–46.
27. Pollock ML, Foster C, Schmidt D, Hellman C, Linnerud AC, Ward A. Comparative analysis of physiologic responses to three different maximal graded exercise test protocols in healthy women. Am Heart J. 1982; 103 (3): 363–73.
28. Rolland Y, Abellan van Kan G, Vellas B. Healthy brain aging: role of exercise and physical activity. Clin Geriatr Med. 2010; 26 (1): 75–87.
29. Seeman TE, Crimmins E. Social environment effects on health and aging: integrating epidemiologic and demographic approaches and perspectives. Ann N Y Acad Sci. 2001; 954: 88–117.
30. Snowden M, Steinman L, Mochan K, et al.. Effect of exercise on cognitive performance in community-dwelling older adults: review of intervention trials and recommendations for public health practice and research. J Am Geriatr Soc. 2011; 59 (4): 704–16.
31. Sui X, LaMonte MJ, Laditka JN, et al.. Cardiorespiratory fitness and adiposity as mortality predictors in older adults. JAMA. 2007; 298 (21): 2507–16.
32. US Department of Health and Human Services. 2008 Physical Activity Guidelines for Americans. Washington (DC): US Department of Health and Human Services; 2008. p. 21–34.